Wave 1 data (2023)

Hover and click over a country to find out more about their pneumococcal vaccination recommendations and coverage rates across the life course.

Recommendations refers to the official recommendation for a specific group by a national health body.

Coverage refers to the percentage of people covered by pneumococcal vaccination. 

  • All
  • CHILDREN *
  • AT-RISK GROUPS **
  • OLDER ADULTS ***
  • Select:
  • CHILDREN
  • AT-RISK GROUPS
  • OLDER ADULTS

Recommendations

Recommendations refers to the official recommendation for a specific group by a national health body.

  • 3 recommendations
  • 2 recommendations
  • 1 recommendation
  • No recommendations

Coverage

Coverage refers to the percentage of people covered by pneumococcal vaccination.

  • Select:
  • CHILDREN *
  • AT-RISK GROUPS **
  • OLDER ADULTS ***
  • > 95%
  • 90 - 94%
  • 85 - 89%
  • 80 - 84%
  • < 80%
  • No data
  • No recommendation

Reimbursement

  • Select:
  • CHILDREN
  • AT-RISK GROUPS
  • OLDER ADULTS
  • Recommendation & funded by national health system
  • Recommendation only (no reimbursement)
  • No recommendation
  • No data

Select to view country profiles:

The Pneumococcal Vaccination Atlas has been developed by the International Longevity Centre UK (ILC-UK). Wave 1 (2023) was developed in partnership with the Coalition for Life Course Immunisation (CLCI). Find out more about ILC and CLCI.

The Pneumococcal Vaccination Atlas initiative has been developed with the support of MSD.

Report an issue: Something doesn’t look right? Contact us